Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD 0.1080
0.00 (0.00%)
At close: Feb 13, 2026
Tianda Pharmaceuticals Market Cap
Tianda Pharmaceuticals has a market cap or net worth of 232.2 million as of February 13, 2026. Its market cap has decreased by -44.90% in one year.
Market Cap
232.20M
Enterprise Value
269.02M
Revenue
310.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since October 27, 1993, Tianda Pharmaceuticals's market cap has decreased from 315.36M to 232.20M, a decrease of -26.37%. That is a compound annual growth rate of -0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 232.20M | -16.28% |
| Dec 31, 2025 | 277.36M | -23.67% |
| Dec 31, 2024 | 363.36M | -22.48% |
| Dec 29, 2023 | 468.71M | -46.17% |
| Dec 30, 2022 | 870.77M | 26.56% |
| Dec 31, 2021 | 688.01M | 131.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pak Fah Yeow International | 747.94M |
| Zhongzhi Pharmaceutical Holdings | 647.70M |
| Fusen Pharmaceutical Company | 554.48M |
| China NT Pharma Group Company | 532.65M |
| Wai Yuen Tong Medicine Holdings | 416.29M |
| Regent Pacific Group | 294.73M |
| Shenzhen Neptunus Interlong Bio-technique Company | 270.16M |
| Extrawell Pharmaceutical Holdings | 201.45M |